Summary
The electrophoretic and column Chromatographic characteristics of an amylase inhibitor of wheat origin were investigated. Further, the clinical usefulness of this inhibitor for determining the ratio of pancreatic to salivary isoamylase activity in serum was evaluated. Amylase inhibitor inhibits the action of salivary α-amylase by making an amylase-inhibitor complex, which is easily separated into its individual component during electroresis with full recovery of amylase activity. Using the specific inhibitory effect of this inhibitor on salivary α- amylase activity, the ratio of pancreatic to salivary isoamylase activity (P/S) in serum was determined. There was a good correlation in P/S ratio in serum between the results obtained with the inhibitor method and those with electrophoretic method. The P/S ratio in sera from patients with acute pancreatitis was over 8.0, whereas that in sera from patients with salivary-type hyperamylasemia such as mumps, pulmonary diseases and following surgery was less than 0.1. However, hyperamylasemia due to macroamylase or renal failure could not be identified by the inhibitor method.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weiss MJ, et al: Elevated serum amylase associated with bronchogenic carcinoma. Am J Clin Pathol 21: 1057, 1951
Otsuki M, et al: Amylase in the lung. Cancer 39: 1656, 1977
Warschaw AL, et al: On the cause of raised serumamylase in diabetic ketoacidosis. Lancet 1: 929, 1977
Hanafy HM, et al: Increased amylase levels in prostatic disease. Urology 1: 372, 1973
Harada K, et al: Isoenzyme study on postoperative transient hyperamylasemia. Am J Gastroenterol 61: 212, 1974
Otsuki M, et al: The nature and origin of hyperamylasemia following open heart surgery with extracorporeal circulation. Clin Chim Acta 77: 349, 1977
Harada K, et al: Immunological and electrophoretical approaches to macroamylase analysis. Clin Chim Acta 59: 291, 1975
Benjamin DR, et al: Clinical value of amylase isoenzyme determination. Am J Clin Pathol 62: 762, 1974
Otsuki M, et al: Electrophoretic pattern of amylase isoenzymes in serum and urine of normal persons. Clin Chem 22: 439, 1976
Takeuchi T, et al: Separation of human α-amylase isoenzymes by electrofocusing and their immunological properties. Clin Chim Acta 60: 207, 1975
Levitt MD, et al: Isoelectric focusing studies of human serum and tissues isoamylase. J Lab Clin Med 90: 141, 1977
Fridhandler L, et al: Isolation and measurement of pancreatic amylase in human serum and urine. Clin Chem 18: 1493, 1972
Berk JE, et al: Clinical application of amylase isoenzyme analysis. Am J Gastroenterol 63: 457, 1975
O’Donnell MD, et al: Purification and properties of α-amylase inhibitor from wheat. Biochim Biophys Acta 422: 159, 1976
O’Donnell MD, et al: Differential serum amylase determination by use of an inhibitor and design of a routine procedure. Clin Chem 23: 560, 1977
Ceska M, et al: A new and rapid method for the clinical determination of α-amylase activities in human serum and urine; optimal conditions. Clin Chim Acta 26: 437, 1969
Suehiro I, et al: Effect of α-glucosidase inhibitor on human pancreatic and salivary α-amylase. Clin Chim Acta 117: 145, 1981
Otsuki M, et al: Relation of electroretic pattern of amylase isoenzymes to severity of pancreatic disease. Clin Chim Acta 79: 1, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suehiro, I., Otsuki, M., Ohki, A. et al. Amylase inhibitor from wheat: Its action and clinical application. Gastroenterol Jpn 19, 313–319 (1984). https://doi.org/10.1007/BF02779120
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02779120